These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Dopaminergic dsyfunction in Tourette syndrome. Singer HS; Butler IJ; Tune LE; Seifert WE; Coyle JT Ann Neurol; 1982 Oct; 12(4):361-6. PubMed ID: 6184010 [TBL] [Abstract][Full Text] [Related]
3. [A study of clinical pictures and monoamine metabolism of Gilles de la Tourette syndrome]. Takano K; Ishiguro T Seishin Shinkeigaku Zasshi; 1993; 95(1):1-29. PubMed ID: 7685527 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in Gilles de la Tourette syndrome: implications for clinical practice and future research. Leckman JF; Cohen DJ Psychiatr Dev; 1983; 1(3):301-16. PubMed ID: 6324164 [TBL] [Abstract][Full Text] [Related]
5. Serum haloperidol levels in Gilles de la Tourette syndrome. Singer HS; Rabins P; Tune LE; Coyle JT Biol Psychiatry; 1981 Jan; 16(1):79-84. PubMed ID: 6939449 [No Abstract] [Full Text] [Related]
6. Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications. Koslow SH; Cross CK Adv Neurol; 1982; 35():185-97. PubMed ID: 6959489 [No Abstract] [Full Text] [Related]
7. Neurobiological basis of serotonin-dopamine antagonists in the treatment of Gilles de la Tourette syndrome. Steeves TD; Fox SH Prog Brain Res; 2008; 172():495-513. PubMed ID: 18772048 [TBL] [Abstract][Full Text] [Related]
8. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats. Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936 [TBL] [Abstract][Full Text] [Related]
9. Genetics, haloperidol and pimozide: a comparative study in two mouse strains. Messiha FS Neurotoxicology; 1991; 12(1):47-54. PubMed ID: 2014068 [TBL] [Abstract][Full Text] [Related]
10. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study]. Scatton B; Zarifian E; Bianchetti G; Cuche H; Loo H; Morselli PL Encephale; 1982; 8(1):1-8. PubMed ID: 7094868 [TBL] [Abstract][Full Text] [Related]
11. [Features of the temporal structure of the respiratory cycle in the Tourette syndrome as a possible reflection of intensified dopaminergic processes]. Shchelkunov EL; Kenunen OG; Voronov IB; Zimin AL; Kharitonov RA Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1500-5. PubMed ID: 3000115 [TBL] [Abstract][Full Text] [Related]
12. Treating Tourette syndrome with haloperidol: predictors of success. Schwabe MJ; Konkol RJ Wis Med J; 1989 Oct; 88(10):23-7. PubMed ID: 2815810 [TBL] [Abstract][Full Text] [Related]
14. Overview of pharmacological approaches to therapy for Tourette syndrome. van Woert MH; Rosenbaum D; Enna SJ Adv Neurol; 1982; 35():369-75. PubMed ID: 6183950 [No Abstract] [Full Text] [Related]
15. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs. Henderson MG; McMillen BA Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151 [TBL] [Abstract][Full Text] [Related]
16. Sleep in Gilles de la Tourette syndrome. Mendelson WB; Caine ED; Goyer P; Ebert M; Gillin JC Biol Psychiatry; 1980 Apr; 15(2):339-43. PubMed ID: 6932227 [TBL] [Abstract][Full Text] [Related]
17. Effects of Chinese herbal medicine Ningdong granule on regulating dopamine (DA)/serotonin (5-TH) and gamma-amino butyric acid (GABA) in patients with Tourette syndrome. Wang S; Qi F; Li J; Zhao L; Li A Biosci Trends; 2012 Aug; 6(4):212-8. PubMed ID: 23006968 [TBL] [Abstract][Full Text] [Related]
18. Behavioral effects of haloperidol in young Tourette syndrome patients. Bogomolny A; Erenberg G; Rothner AD Adv Neurol; 1982; 35():427-32. PubMed ID: 6959520 [No Abstract] [Full Text] [Related]
19. Decreased serotoninergic activity in Tourette syndrome. Crosley CJ Ann Neurol; 1979 Jun; 5(6):596-7. PubMed ID: 289336 [No Abstract] [Full Text] [Related]